AARTIDRUGS Aarti Drugs Ltd. Stock Price, Charts, Details and Latest News

Edit this post
Aarti Drugs (AARTIDR), a pharmaceutical company, manufactures and sells bulk drugs and specialty chemicals worldwide. Part of the USD 265 million Aarti group, the company was incorporated on Sept. 28, 1984 as a private limited company and went public on July 1, 1992. Chandrakant V. Gogri is the chairman, and the managing director is Prakash M. Patil.

 The company focuses on the anti-diarrhea, anti-inflammatory therapeutic groups. With eight manufacturing facilities in Tarapur and Sarigam, the company manufactures vitamins, anti-arthritis, anti-fungal, antibiotics, ACE inhibitors, anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs. It has products like Aceclofenac, Metronidazole, Ketoconazole, Ciprofloxacin HCl and Metformin HCl to name a few.

The company has already commissioned and made operational its new multipurpose manufacturing facility strictly designed and built in accordance with USFDA requirements. The manufacturing-units of ADL are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all units with one already approved. ADL has developed a state-of-the-art R&D center in Turbhe, Mumbai. It also have two inbuilt supporting R&D centers within the manufacturing sites which all are well recognized by Department of Science and Industrial Research, Government of India. Suyash Laboratories is a subsidiary of the company.

The company has a joint venture Huanggang Yinhe Aarti Pharmaceutical Company to sell its drug ingredients in China. The company is engaged in contract manufacturing and has developed anti-fouling agents. The company exports to more than 85 countries with clients like Sanofi, Aventis, Merck, ..etc. The registered office is at Plot No. N-198, MIDC, Tarapur, Pamtembhi village, Palghar taluka, Thane-401506, Maharashtra and corporate office at Mahendra Industrial Estate, Ground floor, Road No. 29, Plot No. 109-D, Sion (East), Mumbai-400022. Financials The company disclosed fall of 23.45% in standalone net profit on y-o-y basis to Rs 51.90 million, while total income dropped 9.62% y-o-y basis to Rs 1.08 billion for the quarter ended September 2010.

Make use of Bank Nifty Expert Advice every day and start making a profit on a daily basis with a small capital of Rs 5000-10000 as the aim is to trade less but trade accurately.

Nifty / Bank Nifty Option Tip

Looking to trade intraday Nifty or Bank Nifty options? Our Nifty / Bank Nifty Option Tip shares trading calls with a defined entry, target and stop loss, so you know your risk before you trade. It suits traders who follow the market on a trading screen as well as those who place orders through their broker or by phone. Click on Image or Post Title to Read More.

Latest Video Reviews by Clients

Watch video reviews recorded by our clients about their experience with Indian-Share-Tips.com services, including the Nifty / Bank Nifty Option Tip and Delivery Tip. Click on Image or Post Title to Read More.

Awards and Recognition

See the awards and recognition Indian-Share-Tips.com has received over the years for its work in stock market research and investor education. Click on Image or Post Title to Read More.